Φορτώνει......
Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date
Melissa Bersanelli, Francesco Leonardi, Sebastiano Buti University Hospital of Parma, Medical Oncology Unit, Parma, Italy Background: In the past few years, new drugs made their appearance in the first-line setting of treatment for metastatic renal cell carcinoma (mRCC), and cabozantinib is one amon...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2018-09-01
|
| Σειρά: | Cancer Management and Research |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.dovepress.com/spotlight-on-cabozantinib-for-previously-untreated-advanced-renal-cell-peer-reviewed-article-CMAR |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|